RS57651B1 - Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof - Google Patents
Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereofInfo
- Publication number
- RS57651B1 RS57651B1 RS20181008A RSP20181008A RS57651B1 RS 57651 B1 RS57651 B1 RS 57651B1 RS 20181008 A RS20181008 A RS 20181008A RS P20181008 A RSP20181008 A RS P20181008A RS 57651 B1 RS57651 B1 RS 57651B1
- Authority
- RS
- Serbia
- Prior art keywords
- amyloids
- beta
- producing
- novel composition
- extracorporeal reduction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261638672P | 2012-04-26 | 2012-04-26 | |
| PCT/PH2013/000005 WO2013162387A1 (en) | 2012-04-26 | 2013-01-30 | Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof |
| PH12013000037 | 2013-01-30 | ||
| EP13781268.1A EP2841447B1 (en) | 2012-04-26 | 2013-01-30 | Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS57651B1 true RS57651B1 (en) | 2018-11-30 |
Family
ID=49483563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20181008A RS57651B1 (en) | 2012-04-26 | 2013-01-30 | Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20150087591A1 (en) |
| EP (1) | EP2841447B1 (en) |
| JP (1) | JP2015515491A (en) |
| KR (2) | KR20150022753A (en) |
| CN (2) | CN104662032A (en) |
| AU (2) | AU2013253098A1 (en) |
| CA (1) | CA2871585A1 (en) |
| DK (1) | DK2841447T3 (en) |
| ES (1) | ES2685374T3 (en) |
| HR (1) | HRP20181365T1 (en) |
| IN (1) | IN2014MN02137A (en) |
| LT (1) | LT2841447T (en) |
| PL (1) | PL2841447T3 (en) |
| RS (1) | RS57651B1 (en) |
| SG (1) | SG11201406972UA (en) |
| SI (1) | SI2841447T1 (en) |
| WO (1) | WO2013162387A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106800590B (en) * | 2015-11-25 | 2021-04-09 | 杭州智鹤丹谷生物医药有限公司 | Polypeptide combining multiple amyloid protein monomers and aggregates and application thereof |
| CN105651840B (en) * | 2016-04-01 | 2017-12-26 | 商丘师范学院 | A kind of para-immunity electrochemical sensor for detecting amyloid beta oligomer and preparation method thereof |
| CN109954128A (en) * | 2019-03-08 | 2019-07-02 | 南开大学 | It is a kind of to may interfere with beta-amyloid aggregation and assist the functionalized nano gel removed and preparation method |
| CN114933635B (en) * | 2021-08-29 | 2023-05-19 | 武汉夫图生物科技有限公司 | Nano small peptide FH and application thereof in preparation of drugs for treating and preventing fundus vascular diseases |
| US20230201438A1 (en) * | 2021-12-23 | 2023-06-29 | Fresenius Medical Care Holdings, Inc. | Compounds, systems, and techniques for removal of peripheral amyloid beta peptide with albumin binding competitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5223199B2 (en) * | 1972-05-27 | 1977-06-22 | ||
| JPS4942189A (en) * | 1972-08-29 | 1974-04-20 | ||
| CA2214247C (en) * | 1995-03-14 | 2004-02-10 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
| JPH09157283A (en) * | 1995-12-13 | 1997-06-17 | Tatsuaki Yamaguchi | Colloid for adsorbing phosphoric acid |
| US6022859A (en) * | 1996-11-15 | 2000-02-08 | Wisconsin Alumni Research Foundation | Inhibitors of β-amyloid toxicity |
| AU2003303198A1 (en) * | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| US20060069010A1 (en) * | 2003-10-17 | 2006-03-30 | Senicure Llc | Detoxification depot for Alzheimer's disease |
| US20070092508A1 (en) * | 2005-10-21 | 2007-04-26 | Recombiant Technologies, Llc | Detoxification depot for Alzheimer's disease |
| EP2501413B1 (en) * | 2009-11-18 | 2019-03-27 | Nektar Therapeutics | Acid salt forms of polymer-drug conjugates |
| CN102108119A (en) * | 2009-12-25 | 2011-06-29 | 天津键凯科技有限公司 | Multi-arm polyethylene glycol derivative, combination thereof with medicine, and gel |
| JP5843345B2 (en) * | 2010-07-08 | 2016-01-13 | 旭化成メディカル株式会社 | β-amyloid removal system |
-
2013
- 2013-01-30 LT LTEP13781268.1T patent/LT2841447T/en unknown
- 2013-01-30 EP EP13781268.1A patent/EP2841447B1/en active Active
- 2013-01-30 SG SG11201406972UA patent/SG11201406972UA/en unknown
- 2013-01-30 CA CA2871585A patent/CA2871585A1/en active Pending
- 2013-01-30 CN CN201380027665.5A patent/CN104662032A/en active Pending
- 2013-01-30 WO PCT/PH2013/000005 patent/WO2013162387A1/en active Application Filing
- 2013-01-30 ES ES13781268.1T patent/ES2685374T3/en active Active
- 2013-01-30 US US14/397,486 patent/US20150087591A1/en not_active Abandoned
- 2013-01-30 IN IN2137MUN2014 patent/IN2014MN02137A/en unknown
- 2013-01-30 KR KR20147030161A patent/KR20150022753A/en not_active Application Discontinuation
- 2013-01-30 DK DK13781268.1T patent/DK2841447T3/en active
- 2013-01-30 KR KR1020187030342A patent/KR20180117226A/en not_active Application Discontinuation
- 2013-01-30 AU AU2013253098A patent/AU2013253098A1/en not_active Abandoned
- 2013-01-30 CN CN201811292445.6A patent/CN109731169A/en active Pending
- 2013-01-30 JP JP2015508893A patent/JP2015515491A/en active Pending
- 2013-01-30 PL PL13781268T patent/PL2841447T3/en unknown
- 2013-01-30 RS RS20181008A patent/RS57651B1/en unknown
- 2013-01-30 SI SI201331147T patent/SI2841447T1/en unknown
-
2016
- 2016-07-25 AU AU2016208257A patent/AU2016208257B2/en not_active Ceased
-
2018
- 2018-08-27 HR HRP20181365TT patent/HRP20181365T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016208257A1 (en) | 2016-08-11 |
| SG11201406972UA (en) | 2014-11-27 |
| AU2013253098A2 (en) | 2015-04-30 |
| SI2841447T1 (en) | 2018-10-30 |
| PL2841447T3 (en) | 2019-03-29 |
| ES2685374T3 (en) | 2018-10-08 |
| LT2841447T (en) | 2018-09-10 |
| CA2871585A1 (en) | 2013-10-31 |
| HRP20181365T1 (en) | 2018-10-19 |
| EP2841447A4 (en) | 2015-10-28 |
| DK2841447T3 (en) | 2018-09-03 |
| EP2841447B1 (en) | 2018-06-13 |
| CN104662032A (en) | 2015-05-27 |
| KR20180117226A (en) | 2018-10-26 |
| AU2016208257B2 (en) | 2018-08-16 |
| EP2841447A1 (en) | 2015-03-04 |
| IN2014MN02137A (en) | 2015-08-21 |
| KR20150022753A (en) | 2015-03-04 |
| US20150087591A1 (en) | 2015-03-26 |
| AU2013253098A1 (en) | 2014-11-13 |
| JP2015515491A (en) | 2015-05-28 |
| WO2013162387A1 (en) | 2013-10-31 |
| CN109731169A (en) | 2019-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE037048T2 (en) | Methods of producing 4-cycloalkyloxybenzenesulfonamides | |
| FI2841431T4 (en) | Dihydrate of benzothiophene compound and process for producing the same | |
| HK1218724A1 (en) | Composition for the treatment of fistula | |
| GB2503842B (en) | Composition and method of manufacture | |
| SG11201502932TA (en) | Compounds and methods for the production of suckerin and uses thereof | |
| HRP20181365T1 (en) | Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof | |
| GB2503334B (en) | Metal-organic framework compounds and their method of manufacture | |
| IL234606A0 (en) | Novel methods and composition for treatment of disease | |
| SG11201406623PA (en) | Process for the preparation of rivaroxaban and intermediates thereof | |
| HRP20181931T1 (en) | Continuous process for the preparation of (s)-2-acetyloxypropionic acid | |
| IL236450A0 (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| PL399419A1 (en) | Process for the preparation of 4-methoxydihydrochalcone | |
| PL399418A1 (en) | Process for the preparation of 4-methoxydihydrochalcone | |
| GB201509165D0 (en) | Tampon method of manufacture | |
| EP2866757A4 (en) | Tampon method of manufacture | |
| PT2841447T (en) | Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof | |
| HUP1200675A2 (en) | Process for the preparation of pyrimidinyl-piperazines | |
| HUP1100394A2 (en) | Eardrop composition and process for producing this |